Suppr超能文献

路易体痴呆和阿尔茨海默病视觉感知的纵向测试。

Longitudinal testing of visual perception in dementia with Lewy bodies and Alzheimer's disease.

机构信息

Newcastle Magnetic Resonance Centre, Institute of Cellular Medicine, Campus for Ageing and Vitality, Newcastle University, Newcastle, UK.

出版信息

Int J Geriatr Psychiatry. 2013 Jun;28(6):567-72. doi: 10.1002/gps.3860. Epub 2012 Jul 22.

Abstract

OBJECTIVES

Visuo-perceptual abnormalities are a prominent feature in dementia with Lewy bodies (DLB) and also occur in Alzheimer's disease (AD) to a lesser extent. We studied the progression of visuo-perceptual abnormalities over a 12-month period in DLB and AD by using a novel computerised test battery.

METHODS

Following our previous work using the Newcastle Visual Perception (NEVIP) battery, we re-assessed 16 AD, 12 DLB and 28 similar-aged comparison participants 12 months after initial baseline assessment.

RESULTS

DLB visual perception at follow-up showed worse performance than AD (U = 43, p = 0.027); however, there were no significant changes in visuo-perceptual scores between baseline assessment and 12-month assessment within groups. A poor baseline score on the NEVIP predicted subsequent deterioration on the Bristol Activities of Daily Living Scale (rs  = -0.725, p = 0.014) in DLB participants but not in the AD group.

CONCLUSIONS

The NEVIP is a reliable test of visuo-perception, relatively independent of cognitive decline, with predictive value in identifying DLB participants at risk of functional decline. Visuo-perceptual dysfunction is a core feature of the disorder for some DLB patients and was stable over the 12-month period examined here.

摘要

目的

视知觉异常是路易体痴呆(DLB)的一个突出特征,在阿尔茨海默病(AD)中也有较轻程度的发生。我们通过使用一种新型计算机测试电池,研究了 12 个月内 DLB 和 AD 中视知觉异常的进展情况。

方法

在使用纽卡斯尔视觉感知(NEVIP)电池进行了先前的工作之后,我们在最初的基线评估后 12 个月重新评估了 16 名 AD、12 名 DLB 和 28 名年龄相近的对照组参与者。

结果

与 AD 相比,DLB 在随访时的视觉感知表现更差(U=43,p=0.027);然而,各组在基线评估和 12 个月评估之间,视知觉评分均无显著变化。NEVIP 的基线评分较差预示着 DLB 参与者随后在布里斯托尔日常生活活动量表(Bristol Activities of Daily Living Scale)上的恶化(rs=-0.725,p=0.014),但在 AD 组中则无此情况。

结论

NEVIP 是一种可靠的视知觉测试,与认知衰退相对独立,对识别有功能下降风险的 DLB 参与者具有预测价值。对于某些 DLB 患者来说,视知觉功能障碍是该疾病的核心特征,在我们这里检查的 12 个月期间保持稳定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验